Connect with us

Technology

Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions

Published

2 years ago

on

CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ — Flagship Pioneering, the bioplatform innovation company, today announced additions to its leadership team through key executive appointments and promotions. Today’s personnel announcement accompanies Flagship’s announced expansion of its capital base with a capital pool of $3.6 billion to support the origination and growth of an estimated 25 breakthrough platform companies in human health, sustainability, and AI.

Lovisa Afzelius, Ph.D., has been promoted to General Partner. Afzelius joined Flagship in 2020 after leading Pfizer’s systems immunology function, where she served as executive director of clinical programs. A computational scientist by training, Afzelius came to Flagship with twenty years of leadership experience. Afzelius’ past roles included CEO, co-founder, president, chairperson of the board, and executive director in both emerging biotech and large pharma companies.

“Lovisa has showcased her exemplary leadership, vision, and commitment to pioneering original science, as evidenced by her instrumental role in the creation and scaling-up of Alltrna, Apriori Bio, Metaphore Biotechnologies, and Prologue Medicines,” said Noubar Afeyan, Ph.D., Founder and CEO of Flagship Pioneering. “I am pleased with the promotion of Lovisa to General Partner, and look forward to her continued dedication to our mission.”

Paul Biondi has also been promoted to General Partner. Biondi joined Flagship in 2019 following nearly two decades at Bristol-Myers Squibb (BMS), where he most recently served as Senior Vice President of Strategy and Business Development. As President of Flagship’s Pioneering Medicines, Biondi has grown the initiative into a robust drug development unit with a leading team of experts who bring a broad set of capabilities to Flagship and its platforms. Under Biondi’s leadership, Pioneering Medicines has established strategic partnerships with the Cystic Fibrosis Foundation, Novo Nordisk, and Pfizer.

“In just four years since he joined Flagship, Paul has transformed then nascent Pioneering Medicines into an innovation powerhouse, where thanks to his vision and leadership, we boast an R&D unit full of experts who bring an array of drug research, design and development capabilities to our organization,” said Afeyan. “The strategic partnerships he has established signify not just a tremendous opportunity for patient impact and value creation, but represent a new, innovation supply chain model for collaborations within the broader biopharma ecosystem. Beyond this, Paul has provided instrumental leadership in various capacities across Flagship and has positively impacted our growth trajectory.”

Dina Ciarimboli has been appointed as General Counsel and Executive Partner to oversee legal, corporate, IP, compliance, and related matters for Flagship Pioneering and its ecosystem of internally-operated companies. She was most recently General Counsel at EQRx, and brings over 30 years of experience advising life sciences companies and venture capital funds on corporate strategy and operations spanning company creation, early research, clinical development, and commercial launch. Ciarimboli leads legal, corporate, IP, compliance, and related matters for Flagship Pioneering and its early stage, wholly owned companies. 

“We are pleased to have Dina Ciarimboli on board as our General Counsel,” added Afeyan. “Dina’s impressive track record includes over three decades of invaluable experience advising life sciences companies and venture capital funds, which makes her a great fit for this role. Dina’s expert guidance and counsel have quickly become an asset to Flagship and its wholly-owned companies.”

Marcello Damiani has been appointed Senior Partner with a responsibility for guiding and supporting Flagship and its ecosystem companies on digital, IT strategy and operations. Damiani joins Flagship from Moderna where he served as Chief Digital and Operational Excellence Officer, developing and leading a digitization strategy using cutting edge technologies such as robotics, automation cloud computing, and artificial intelligence/machine learning in support of Moderna’s transition from preclinical through to commercial therapeutics.

“Marcello executed a potent digitization strategy during his time at Moderna, using advanced technologies like robotics, automation, cloud computing, and artificial intelligence/machine learning, and his expertise makes him an invaluable addition to our team,” added Afeyan.

Gary Pisano, Ph.D., a long-time contributor to Flagship and for the last year an academic partner while on sabbatical from Harvard Business School, has joined Flagship full time as Executive Partner and Chief Strategist. Pisano most recently served as the Harry E. Figgie, Jr. Professor of Business Administration at the Harvard Business School, where he served as Senior Associate Dean for Promotions and Tenure and has taught MBA, executive, and doctoral courses. As Chief Strategist, Pisano is tasked with tackling the broad strategic and business model choices facing Flagship with a focus on operating effectively and efficiently at scale. Pisano will also be an important resource to Flagship companies on strategy and business model design.

“We have long valued Gary’s insight and strategy at Flagship, and we are pleased to welcome him as our Chief Strategist,” added Afeyan. “Gary’s counsel and singular understanding of the Flagship model will allow him to tackle the broad strategic and business choices facing Flagship with a focus on operating effectively and efficiently at scale. A key part of his role will be helping us leverage the company’s nearly 25 years of experience, and ensuring that Flagship operates on the leading edge of management, strategy, and leadership practice.”

Enhancing Flagship’s Leadership Team

Flagship further enhanced its leadership team with the following executive appointments and elevations:

Junaid Bajwa, M.D., will join Flagship in early September as Senior Partner and Head of United Kingdom, and Science Partner for Pioneering Intelligence. He will focus on advancing new strategic opportunities and partnerships in the region for Flagship and its companies. Bajwa will join Flagship from Microsoft Research where he has been serving as Chief Medical Scientist focusing on how trusted, reliable, and human-centered AI can transform the practice of medicine. He will bring over two decades of experience across primary care, secondary care, and public health settings, and has worked as a payer and policymaker in the UK, specializing in informatics, digital transformation, and leadership.David Khougazian was recently promoted to Executive Partner, Growth and Head of Global Engagement. David brings more than 25 years of leadership experience in the global healthcare industry including over two decades at Sanofi.Justine Levin-Allerhand, Ph.D., was recently promoted to Executive Partner, Origination and Corporate Development to maximize the effectiveness of Flagship’s origination teams, thereby fueling its ecosystem with exceptional company generation and novel, durable scientific platforms.Mark Stevenson joined Flagship as Senior Partner. In this role, he will help advance Flagship’s new Enabling Technologies Initiative (ETI) and focus on driving our external partnerships. Mark brings over 30 years in the life science industry to this role, including as Executive Vice President and Chief Operating Officer of Thermo Fisher.Flagship has also expanded its rank of origination partners through the promotions of Kyle Chiang, Molly Gibson, Scott Lipnick, Armen Mkrtchyan, and Jacob Rubens.

“Flagship is dedicated to hiring and nurturing world-class executives with a history of extraordinary performance, and with these additions to our already robust leadership team, I believe we are in the strongest place we’ve been in our nearly 25-year history,” added Afeyan. “We are pleased to congratulate our colleagues on their new and expanded leadership roles. We look forward to their collaboration as we build on our mission to invent transformative technologies and companies that improve human health and the sustainability of our planet.”

About Flagship Pioneering

Flagship Pioneering invents and builds bioplatform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $75 billion in aggregate value. To date, Flagship has deployed over $3.8 billion in capital toward the founding and growth of its pioneering companies alongside more than $27 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 40 companies, including Foghorn Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Generate Biomedicines, Inari, Indigo Agriculture,  and Tessera Therapeutics.

Media Contact

press@flagshippioneering.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/flagship-pioneering-expands-leadership-team-with-key-appointments-and-promotions-302192734.html

SOURCE Flagship Pioneering

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Innoscience’s current products are not affected by both rulings of the Munich Regional Court

Published

5 minutes ago

on

June 19, 2026

By

MUNICH, June 18, 2026 /PRNewswire/ — Innoscience today announced that the Munich Regional Court has just issued a pair of rulings, from which it could be confirmed that Innoscience’s currently marketed gallium nitride (“GaN”) power device products fall outside the scope of Infineon’s asserted German patents and may be commercialized in Germany without restriction.

These rulings are fully consistent with the final determination issued last month by the U.S. International Trade Commission (“ITC”), which found that Innoscience’s current products do not infringe Infineon’s asserted U.S. patent relating to packaging design (U.S. Patent No. 9,899,481). The Munich case concerns the German counterparts of that same patent family. In line with the ITC’s findings, the Munich Court found infringement only with respect to a limited set of legacy products—certain packaged 650–700V transistors—that had already been discontinued. Therefore, any injunction granted would not apply to Innoscience’s current product portfolio. As a result, there is no impact on Innoscience’s ongoing operations or its customers’ use of its products in Germany.

The decisions mark another significant milestone in Innoscience’s string of favorable outcomes across major jurisdictions. They follow the company’s recent success in China, where it secured an injunction and damages award against Infineon, as well as its decisive victory at the ITC in the United States last month. Together, these rulings reaffirm the legality of Innoscience’s current product portfolio and its ability to operate freely in key global markets.

While proceedings in Germany remain ongoing, including Innoscience’s invalidity challenges to the asserted German patent, the growing body of decisions across China, the United States, and Germany underscores that the global litigation campaign initiated by Infineon has not altered the competitive position of Innoscience’s core products. To the contrary, independent judicial findings across multiple jurisdictions have consistently validated the robustness of Innoscience’s technology and reinforced market confidence in the company’s product compliance and innovation capabilities.

Innoscience remains committed to advancing its technology leadership and expanding its global footprint, delivering cutting-edge GaN solutions to customers worldwide in a fair and competitive marketplace.

View original content:https://www.prnewswire.com/news-releases/innosciences-current-products-are-not-affected-by-both-rulings-of-the-munich-regional-court-302805093.html

SOURCE InnoScience

Continue Reading

Technology

NetZoom Announces Data Center Infrastructure Management Solution for Higher Education Institutions

Published

1 hour ago

on

June 19, 2026

By

NetZoom® is a robust DCIM for managing College and University data centers, campus infrastructure and smart classrooms

CHICAGO, June 18, 2026 /PRNewswire-PRWeb/ — NetZoom offers an intuitive Data Center Infrastructure Management (DCIM) solution designed to help colleges and universities document, visualize, and manage the infrastructure supporting campus IT services, research computing, smart classrooms, and distributed data center environments.

NetZoom helps colleges and universities establish a reliable source of truth, improve operational planning, and support critical infrastructure without adding unnecessary burden to IT and facilities teams.

Higher education institutions often manage infrastructure spread across data centers, MDF/IDF closets, labs, classrooms, and multiple campus locations while supporting digital learning, campus connectivity, research workloads, and administrative systems. These environments require accurate asset management, reliable connectivity documentation, capacity planning, and operational visibility across IT and facilities.

Common infrastructure management challenges in higher education include:

Lack of a single source of truth for asset managementDistributed assets across the entire campusLimited space, power, cooling, and budget resources as digital learning, research computing, and campus IT services continue to expandMaintaining uptime and resiliency for critical academic, research, and administrative systems

“Higher education institutions are managing increasingly complex data center environments that support students, faculty, research, and campus-wide digital services,” said Uriel Campos, General Manager at NetZoom, Inc. “To manage these environments effectively, teams need clear visibility into their assets, connectivity, capacity, power, and cooling. NetZoom helps colleges and universities establish a reliable source of truth, improve operational planning, and support critical infrastructure without adding unnecessary burden to IT and facilities teams.”

NetZoom also supports IT and facilities teams by centralizing asset, connectivity, capacity, power, cooling, and change management data in a visual DCIM platform. By bringing these functions together, institutions can improve resource planning, reduce reliance on manual tracking, identify capacity constraints, and better understand the impact of infrastructure changes.

NetZoom’s DCIM solution offers significant benefits to higher education institutions including:

Campus-wide infrastructure visibility: Helps IT and facilities teams maintain a centralized view of assets across data centers, MDF/IDF closets, labs, classrooms, and distributed campus locations.Improved planning for space, power, and cooling: Provides visibility into capacity utilization so institutions can better support growing digital learning, research computing, and administrative systems.Reduced reliance on manual tracking: Centralizes asset, connectivity, capacity, and change management data to help reduce spreadsheet dependency, duplicate records, and inconsistent documentation.Operational support for limited IT resources: Helps streamline day-to-day infrastructure management, giving campus teams better access to the information needed to plan changes, troubleshoot issues, and manage equipment lifecycles.Scalable support for evolving campus technology: Allows institutions to start with core DCIM functions and expand into areas such as monitoring, reporting, service management, integrations, and advanced capacity planning as their needs grow.

Availability

NetZoom DCIM for Higher Education is immediately available in both SaaS and On-Premises deployments. For demonstrations, POCs, pricing and deployment options, contact NetZoom at 630-281-6464, email Sales@NetZoom.com or visit NetZoom.com

About NetZoom

Founded in 1995, NetZoom, Inc. is an Illinois corporation with headquarters in the Chicago area. NetZoom offers a flexible and powerful application that integrates with on-premise, virtual and cloud resources and many third-party tools like ServiceNow® to create a complete DCIM solution for data center professionals worldwide to effectively model, manage, monitor and maximize IT and Facility infrastructure.

For more information, visit NetZoom.com

NetZoom is a registered trademark of NetZoom, Inc. All other marks and names are trademarks of their respective companies.

Media Contact

Marketing Department, NetZoom, Inc., 1 630-281-6464, Marketing@NetZoom.com, https://NetZoom.com

View original content to download multimedia:https://www.prweb.com/releases/netzoom-announces-data-center-infrastructure-management-solution-for-higher-education-institutions-302804934.html

SOURCE NetZoom, Inc.

Continue Reading

Technology

NOVVA Group acquires 120 MWp Philippines solar project, anchoring its AI-era power platform in Southeast Asia

Published

1 hour ago

on

June 19, 2026

By

HONG KONG, June 19, 2026 /PRNewswire/ — NOVVA Group (“Novva”), a global AI-enabling energy infrastructure platform, announced today that it has signed a definitive agreement to acquire 100% of San Jose Solar Power Plant (“SJSP”), a utility-scale solar PV project in Bukidnon, Mindanao, from Mabuhay Power Holdings Corporation. The acquisition marks Novva’s first investment in the Philippines and a critical milestone in its strategy to build a scalable, bankable power platform across Southeast Asia.

SJSP is a 120 MWp greenfield solar project located in Barangay San Jose, in the Municipality of Quezon, Bukidnon. Once operational, it is expected to generate over 200 GWh of clean electricity per year. Construction is scheduled to begin in Q1 2027, with commercial operation targeted for 2028.

The transaction comes amid an unprecedented surge in Asian power demand, driven by the rapid expansion of artificial intelligence, cloud computing, and digital infrastructure. With energy availability emerging as the primary constraint on sustained economic growth, resilient power infrastructure has become vital. The project also advances the Philippines’ goal of a 35% renewable energy share by 2030, channelling clean capacity into one of Southeast Asia’s fastest-growing digital economies.

Steven Liu, Founder and CEO of Novva, said: “Power availability has become one of the defining constraints on future growth. With SJSP, we are securing the strategic infrastructure needed to support the next wave of industrial and digital development. By combining disciplined execution with long-term partnerships, Novva is building a reliable clean energy foundation to power the future of Southeast Asia.”

SJSP will integrate directly into Novva’s regional platform, which combines renewable generation, flexible power solutions, energy storage, grid connectivity and infrastructure financing capabilities. Novva remains committed to scaling clean energy capacity to sustain the next generation of hyperscale data centres and digital economies.

About Novva
Novva (NOVVA Group Pte. Ltd.) is a global AI-enabling energy infrastructure platform that originates, finances, builds, and operates bankable clean energy assets across Southeast Asia and Latin America. As digital transformation drives an unprecedented increase in global electricity demand, Novva scales its clean power capabilities to build the reliable energy foundation for the AI era and beyond.
www.novvaglobal.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/novva-group-acquires-120-mwp-philippines-solar-project-anchoring-its-ai-era-power-platform-in-southeast-asia-302805075.html

SOURCE NOVVA Group

Continue Reading

Trending